Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q1 2021 to Q2 2021
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 3
- Est. +$4.33M
- Added
- 41
- Est. +$6.11M
- Reduced
- 10
- Est. −$822.5K
- Sold out
- 4
- Est. −$3.28M
Portfolio value went from $234.7M to $252.1M (+$17.5M (+7.4%)); positions from 67 to 66 (−1).
All Q2 2021 holdingsAll Q1 2021 holdings
In the shares, value and % of portfolio columns, the top figure is Q2 2021 and the gray one below is Q1 2021. For stocks that split between the two quarters, Q1 2021 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| EIGREiger BioPharmaceuticals, Inc. | ReducedHistory | 10,02710,763 | −736−6.8% | $82.0K$97.0K | −$6.02K | <0.1%<0.1% | −0.01 |
| HSICHenry Schein Inc | ReducedHistory | 2,8083,135 | −327−10.4% | $206.0K$217.0K | −$24.0K | 0.1%0.1% | −0.01 |
| REGNRegeneron Pharmaceuticals, Inc. | ReducedHistory | 422505 | −83−16.4% | $235.0K$238.0K | −$46.2K | 0.1%0.1% | −0.01 |
| CVSCVS Health Corp | ReducedHistory | 2,8272,967 | −140−4.7% | $237.0K$226.0K | −$11.7K | 0.1%0.1% | 0.00 |
| JNJJohnson & Johnson | ReducedHistory | 1,7881,793 | −5−0.3% | $296.0K$294.0K | −$827.74 | 0.1%0.1% | −0.01 |
| NVDANVIDIA Corp | ReducedHistory | 506630 | −124−19.7% | $405.0K$337.0K | −$99.2K | 0.2%0.1% | +0.02 |
| ProShares Tr74347R842 | ReducedConverted for a 2-for-1 split– | 10,61910,710 | −91−0.8% | $634.0K$599.0K | −$5.43K | 0.3%0.3% | 0.00 |
| iShares MSCI USA Min Vol Factor ETF46429B697 | Reduced– | 35,15335,364 | −211−0.6% | $2.58M$2.45M | −$15.5K | 1.0%1.0% | −0.02 |
| iShares Tr464288661 | Reduced– | 22,84927,067 | −4,218−15.6% | $2.98M$3.52M | −$550.3K | 1.2%1.5% | −0.32 |
| iShares Core S&P 500 ETF464287200 | Reduced– | 28,48828,635 | −147−0.5% | $12.2M$11.4M | −$63.2K | 4.9%4.9% | 0.00 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.